PL2722331T3 - Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania - Google Patents

Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania

Info

Publication number
PL2722331T3
PL2722331T3 PL12800143T PL12800143T PL2722331T3 PL 2722331 T3 PL2722331 T3 PL 2722331T3 PL 12800143 T PL12800143 T PL 12800143T PL 12800143 T PL12800143 T PL 12800143T PL 2722331 T3 PL2722331 T3 PL 2722331T3
Authority
PL
Poland
Prior art keywords
crystal
disodium salt
producing same
pyrroloquinolinequinone
pyrroloquinolinequinone disodium
Prior art date
Application number
PL12800143T
Other languages
English (en)
Inventor
Kazuto Ikemoto
Hitoshi Sakamoto
Original Assignee
Mitsubishi Gas Chemical Company, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Company, Inc. filed Critical Mitsubishi Gas Chemical Company, Inc.
Publication of PL2722331T3 publication Critical patent/PL2722331T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/66—Preparation of oxygen-containing organic compounds containing the quinoid structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL12800143T 2011-06-16 2012-06-15 Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania PL2722331T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011134279 2011-06-16
PCT/JP2012/065303 WO2012173217A1 (ja) 2011-06-16 2012-06-15 ピロロキノリンキノンジナトリウム塩の結晶およびその製造方法
EP12800143.5A EP2722331B1 (en) 2011-06-16 2012-06-15 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same

Publications (1)

Publication Number Publication Date
PL2722331T3 true PL2722331T3 (pl) 2018-02-28

Family

ID=47357196

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12800143T PL2722331T3 (pl) 2011-06-16 2012-06-15 Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania

Country Status (9)

Country Link
US (1) US9174983B2 (pl)
EP (1) EP2722331B1 (pl)
JP (1) JPWO2012173217A1 (pl)
CN (1) CN103619842B (pl)
DK (1) DK2722331T3 (pl)
ES (1) ES2651238T3 (pl)
NO (1) NO2722331T3 (pl)
PL (1) PL2722331T3 (pl)
WO (1) WO2012173217A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011007633A1 (ja) 2009-07-16 2011-01-20 三菱瓦斯化学株式会社 ピロロキノリンキノンのナトリウム塩結晶
CN102942567B (zh) * 2012-11-09 2017-02-08 诸城市浩天药业有限公司 吡咯并喹啉醌的二钠盐结晶
MA39715A (fr) * 2014-04-16 2015-10-22 Anthem Biosciences Private Ltd Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation
WO2016117242A1 (ja) * 2015-01-19 2016-07-28 三菱瓦斯化学株式会社 溶解性の高いアセトン付加ピロロキノリンキノン塩
WO2017050171A1 (zh) 2015-09-25 2017-03-30 浙江海正药业股份有限公司 吡咯并喹啉醌钠盐的晶型及其制备方法和用途
JP6769705B2 (ja) * 2015-11-30 2020-10-14 株式会社協和 胎盤抽出物の製造方法
EP3480197B1 (en) 2016-06-29 2024-04-03 Mitsubishi Gas Chemical Company, Inc. Pyrroloquinone quinone monosodium, method for manufacturing same, and composition including same
KR102120670B1 (ko) * 2019-01-03 2020-06-10 주식회사 누베파마 돌연변이 균주를 이용한 항산화 물질 생산 방법
CN112125899B (zh) * 2019-06-24 2023-01-03 浙江可明生物医药有限公司 吡咯并喹啉醌二钠盐结晶、其制备方法及包含其的组合物
CN115716825A (zh) * 2021-08-24 2023-02-28 浙江医药股份有限公司新昌制药厂 吡咯并喹啉醌二钠盐结晶、其制备方法及包含其的组合物
CN116850085A (zh) * 2023-08-18 2023-10-10 水羊化妆品制造有限公司 吡咯并喹啉醌二钠盐在修护皮肤屏障中的应用
CN117327069B (zh) * 2023-09-27 2024-04-30 山东原力泰医药科技有限公司 吡咯并喹啉醌二钠盐晶型及其制备方法和应用
CN117777147A (zh) * 2024-02-23 2024-03-29 内蒙古金达威药业有限公司 一种吡咯并喹啉醌二钠盐的晶型及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113024B2 (ja) * 1986-04-17 1995-12-06 三菱瓦斯化学株式会社 ピロロキノリンキノンの精製方法
JP2751183B2 (ja) 1988-02-26 1998-05-18 三菱瓦斯化学株式会社 ピロロキノリンキノンの製造方法
JP2692167B2 (ja) 1988-09-01 1997-12-17 三菱瓦斯化学株式会社 ピロロキノリンキノン類の回収・精製方法
JP3475969B2 (ja) 1993-08-27 2003-12-10 大日本インキ化学工業株式会社 共重合体樹脂エマルジョン、その製造方法及び防湿加工用組成物
BR0107456A (pt) * 2000-01-07 2002-10-08 Transform Pharmaceuticals Inc Formação de amostras, métodos de preparar uma formação de múltiplas formas sólidas de um composto de interesse, de triar uma pluralidade de formas sólidas de um composto de interesse e condições e/ou componentes para compatibilidade com uma ou mais formas sólidas selecionadas de um composto de interesse, de identificar formas sólidas ótimas de um composto de interesse e de determinar conjuntos de condições e/ou componentes para produzir formas sólidas de um composto de interesse, um conjunto de parâmetros de processamento e/ou componentes e as condições e/ou componentes que produzem um composto de interesse ou um seu derivado diastereomérico e sistema para identificar formas sólidas ótimas de um composto de interesse
US7276514B2 (en) 2002-05-15 2007-10-02 Charitable Leadership Foundation - Medical Technology Acceleration Program Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
JP2007269769A (ja) 2006-03-10 2007-10-18 Ultizyme International Ltd 神経変性疾患関連蛋白質凝集線維化抑制剤
WO2011007633A1 (ja) * 2009-07-16 2011-01-20 三菱瓦斯化学株式会社 ピロロキノリンキノンのナトリウム塩結晶
JP2011098911A (ja) 2009-11-06 2011-05-19 Mitsubishi Gas Chemical Co Inc ピロロキノリンキノン粉体
WO2011055796A1 (ja) * 2009-11-06 2011-05-12 三菱瓦斯化学株式会社 ピロロキノリンキノンのフリー体
JP2011246442A (ja) 2010-04-28 2011-12-08 Rohto Pharmaceutical Co Ltd 光老化抑制剤および皮膚菲薄化抑制剤

Also Published As

Publication number Publication date
DK2722331T3 (da) 2017-11-20
EP2722331A1 (en) 2014-04-23
EP2722331A4 (en) 2014-11-05
WO2012173217A1 (ja) 2012-12-20
ES2651238T3 (es) 2018-01-25
US20140128609A1 (en) 2014-05-08
CN103619842A (zh) 2014-03-05
CN103619842B (zh) 2016-06-22
EP2722331B1 (en) 2017-09-06
NO2722331T3 (pl) 2018-02-03
US9174983B2 (en) 2015-11-03
JPWO2012173217A1 (ja) 2015-02-23

Similar Documents

Publication Publication Date Title
PL2722331T3 (pl) Kryształ soli disodowej pirolochinolinochinonu oraz sposób jego wytwarzania
LT2489670T (lt) Aminorūgščių chelatinių junginių gavimo būdas, aminorūgščių chelatiniai junginiai ir aminorūgščių chelatinių junginių panaudojimas
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Methods of Treatment
ZA201305972B (en) Method for the preparation of biphephos
IL213865A0 (en) Antiballistic article and method of producing same
SI2784056T1 (sl) Postopek za selektivno produkcijo n-metil-para anizidina
AP3748A (en) Method of producing hydrocarbons
SG11201400405TA (en) Caninised antibodies and method for the production of same
SG11201402998PA (en) Hydroxy-aminopolymers and method for producing same
EP2668260A4 (en) METHOD FOR MODIFYING BACTERIA
EP2698159A4 (en) PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF
EP2697334A4 (en) PROCESS FOR THE PRODUCTION OF RETAINING AGENTS
PL2805952T3 (pl) Krystaliczna forma soli (6S)-5-metylotetrahydrofolianowej oraz sposób jej przygotowywania
SG11201400974VA (en) Crystal of 5-hydroxy-1h-imidazole-4-carboxamideˑ3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate
IL228285A (en) A compound and method for the production and method for the production of oseltamivir phosphate
EP2757100A4 (en) TRIEPOXID COMPOUND AND METHOD FOR THE PRODUCTION THEREOF
IL230159A0 (en) Method for the production of 2-amino-5-cyano-n,3-dimethylbenzamide
EP2889303A4 (en) CONNECTION OF A CRYSTAL FORM OF ANDROSTA-3B, 5A, 6B-TRIOL AND METHOD FOR THE PRODUCTION THEREOF
EP2729848A4 (en) Fastening element, fastening device and method for producing the fastening element
GB201114798D0 (en) Method of modifying surfaces
EP2791324A4 (en) PROCESSING METHOD
GB201119607D0 (en) Method of manufacture
AU2011901418A0 (en) Method for Production of Proppants
AU2011903214A0 (en) Method of treatment